Multi-antigen vectors for melanoma

Details for Australian Patent Application No. 2004273034 (hide)

Owner Therion Biologics, Inc.

Inventors Gritz, Linda; Parrington, Mark; Berinstein, Neil; Panicali, Dennis; Tartaglia, Jim

Agent Spruson & Ferguson

Pub. Number AU-A-2004273034

PCT Pub. Number WO2005/026370

Priority 60/500,572 05.09.03 US; 60/504,007 18.09.03 US

Filing date 3 September 2004

Wipo publication date 24 March 2005

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

C12N 15/863 (2006.01) Mutation or genetic engineering - Poxviral vectors, e.g. vaccinia virus

Event Publications

9 March 2006 PCT application entered the National Phase

  PCT publication WO2005/026370 Priority application(s): WO2005/026370

17 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004273036-Replaceable plate expanded thermal plasma apparatus and method

2004273029-Stationary phases and a purification process using the stationary phases